Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Delcath Systems, Inc. (DCTH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.34+0.42 (+4.23%)
At close: 4:00PM EDT
9.10 -1.24 (-11.99%)
After hours: 05:11PM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Delcath Systems to Present at Upcoming Virtual Investor Conferences

    NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will participate in three upcoming conferences: H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021 Presentation Date and Time: On-demand beginning 9/13/2021 at 7:00 AM (ET)Webcast: https://journey.ct.events/view/ee8971f7-2bcf-428c-91e5-3ff7d70376abManage

  • GlobeNewswire

    Delcath Systems Announces Second Quarter 2021 Results

    NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today reported business highlights and financial results for the second quarter ended June 30, 2021. Recent Business Highlights During and since the second quarter the company: Had positive efficacy results presented from its FOCUS Phase III trial of HEPZATO™ KIT (melphalan hydrochloride for injection/he

  • GlobeNewswire

    Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

    NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today that it has entered into a debt facility with Avenue Venture Opportunities Fund, L.P. ("Avenue Venture Fund") providing up to $20 million with an initial $15 million funded at close. Additional details concerning the debt facility will be contained in the company's Current Report on Form

Advertisement
Advertisement